EGFR is highly expressed in over 90% of HNSCC (Ishitoya et al., 1989; Grandis and Tweardy, 1993) and strongly associated with poor prognosis (Rubin Grandis et al., 1998; Chung et al., 2006). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.